Uric Acid Kidney Stones: Formation Mechanism, Risk Factors & Prevention

Uric acid stones account for 5–10% of kidney stones (higher in gout, metabolic syndrome). They form when urinary uric acid supersaturates and crystallizes, often at low urine pH.

Pathophysiology

  1. Purine metabolism: Endogenous (cell turnover) + exogenous (diet) → uric acid
  2. Renal handling: 90% reabsorbed (URAT1, GLUT9); 10% excreted
  3. Supersaturation: Urinary [uric acid] > solubility limit (pH-dependent)
  4. Crystallization: Monosodium urate crystals nucleate, aggregate
  5. Stone growth: Epitaxial growth; may combine with calcium oxalate (mixed stones)

Key Risk Factors

  • Low urine pH (<5.5): Primary driver – undissociated uric acid precipitates
  • High purine intake: Red meat, organ meats, shellfish, alcohol (esp. beer)
  • Low urine volume: <2L/day → concentration
  • Metabolic syndrome: Insulin resistance → reduced renal urate excretion, low pH
  • Gout: 20–25% develop stones
  • Genetics: SLC2A9, SLC22A12 variants (urate transporters)
  • Medications: Diuretics, low-dose aspirin, pyrazinamide

Prevention & Treatment

  • Alkalinization (cornerstone): Target urine pH 6.0–6.5 with potassium citrate (20–30 mEq 2–3×/day) or sodium bicarbonate
  • Hydration: >2.5L urine output/day
  • Low-purine diet: Limit animal protein; plant purines less impactful
  • Xanthine oxidase inhibitors: Allopurinol/febuxostat if hyperuricemic + stones/gout
  • Weight loss: Improves insulin sensitivity, urine pH

Diagnostic Advantage

Uric acid stones are radiolucent on plain X-ray (KUB) but visible on CT. Can be dissolved medically (alkalinization) – unlike calcium stones.

24-hour urine collection (supersaturation, pH, volume, uric acid excretion) guides targeted therapy.

Kidney Disease - Related Articles